United Therapeutics Corp’s filing revealed that its Chairperson & CEO ROTHBLATT MARTINE A unloaded Company’s shares for reported $1.8 million on Oct 30 ’25. In the deal valued at $448.96 per share,4,000 shares were sold. As a result of this transaction, ROTHBLATT MARTINE A now holds 130 shares worth roughly $57905.9.
Then, ROTHBLATT MARTINE A sold 4,000 shares, generating $1,743,112 in total proceeds. Upon selling the shares at $435.78, the Chairperson & CEO now owns 130 shares.
Before that, MAHON PAUL A sold 11,000 shares. United Therapeutics Corp shares valued at $4,953,760 were divested by the EVP & GENERAL COUNSEL at a price of $450.34 per share. As a result of the transaction, MAHON PAUL A now holds 36,781 shares, worth roughly $16.38 million.
Wells Fargo initiated its United Therapeutics Corp [UTHR] rating to an Underweight in a research note published on October 20, 2025; the price target was $414. A number of analysts have revised their coverage, including RBC Capital Mkts’s analysts, who began to cover the stock in late September with a ‘”an Outperform”‘ rating. Cantor Fitzgerald began covering UTHR with “an Overweight” recommendation on June 02, 2025. Wells Fargo revised its rating on April 25, 2025. It rated UTHR as “an Equal weight” which previously was an “an Overweight”.
Price Performance Review of UTHR
On Friday, United Therapeutics Corp [NASDAQ:UTHR] saw its stock fall -1.79% to $445.43. Over the last five days, the stock has gained 6.41%. United Therapeutics Corp shares have risen nearly 26.26% since the year began. Nevertheless, the stocks have risen 26.24% over the past one year. While a 52-week high of $479.50 was reached on 10/29/25, a 52-week low of $266.98 was recorded on 04/09/25.
Levels Of Support And Resistance For UTHR Stock
The 24-hour chart illustrates a support level at 439.78, which if violated will result in even more drops to 434.13. On the upside, there is a resistance level at 451.80. A further resistance level may holdings at 458.17.
How much short interest is there in United Therapeutics Corp?
A steep rise in short interest was recorded in United Therapeutics Corp stocks on 2025-10-15, dropping by -0.75 million shares to a total of 2.03 million shares. Yahoo Finance data shows the prior-month short interest on 2025-09-15 was 2.78 million shares. There was a decline of -36.88%, which implies that there is a negative sentiment for the stock.
